Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Va, Petrishchenko"'
Autor:
Va, Zhukov, Ln, Shishkina, As, Safatov, Aa, Sergeev, Iankov Ov, P., Va, Petrishchenko, Bn, Zaĭtsev, Vs, Toporkov, An, Sergeev, Nesvizhskiĭ IuV, Aa, Vorob Ev
Publikováno v:
Europe PubMed Central
The paper presents results of testing a modified algorithm for predicting virus ID50 values in a host of interest by extrapolation from a model host taking into account immune neutralizing factors and thermal inactivation of the virus. The method was
Autor:
Va, Zhukov, Ln, Shishkina, Aa, Sergeev, Iv, Fankin, Ma, Smetannikova, Iankov Ov, P., Va, Petrishchenko, An, Sergeev, Aa, Vorob Ev
Publikováno v:
Europe PubMed Central
To predict a potential value of a viral ID50 for a macro-organism of interest (e.g. humans), it is necessary to determine in vitro two parameters of the interaction of the virus with susceptible cells of the host, i.e. the probability of the virus' p
Autor:
Ma, Smetannikova, Ln, Shishkina, Va, Zhukov, Iv, Fankin, Aa, Sergeev, Mo, Skarnovich, Iankov Ov, P., Va, Petrishchenko, Vn, Bondarenko, An, Sergeev
Publikováno v:
Europe PubMed Central
The results of the study showed that subcutaneous kenalog (Kn) lowered the resistance of mice to influenza virus (InV), as was seen by a decrease in 50% lethal dose and an increase in the degree of pulmonary tissue lesion, and the susceptibility of t
Autor:
Iv, Pliasunov, An, Sergeev, Aa, Sergeev, Va, Petrishchenko, Ln, Shishkina, Vv, Generalov, As, Safatov, Ls, Sandakhchiev, Vv, Udut, Sa, Mel Nikov, Vn, Podkuĭko
Publikováno v:
Europe PubMed Central
Clinical trials of oral live recombinant embryonic variola and hepatitis B bivaccine as tablets (Revax-BT) were performed. When volunteers were prevaccinated with oral variola vaccine first in a small dose and, 7, 14, 30, 90, and 180 days later, in a
Autor:
Aa, Sergeev, An, Sergeev, Va, Petrishchenko, Ln, Shishkina, Gv, Kochneva, Va, Zhukov, Nk, Evtin, Iankov Ov, P., Ls, Sandakhchiev, La, Akinfeeva, Vv, Udut, Sherstoboev EIu, Ed, Gol Dberg, Sa, Mel Nikov, Vn, Podkuĭko, Va, Maksimov
Publikováno v:
Europe PubMed Central
The reactogenicity of the embryonic live recombinant variola and hepatitis B bivaccine as tablets (Revax-BT) as well as its safety and immunogenicity were evaluated in clinical trials made in volunteers who had previously immunized or not with variol
Autor:
Va, Zhukov, As, Safatov, Iankov Ov, P., Vs, Toporkov, Aa, Sergeev, Sa, Kiselev, Va, Iashin, Nm, Beliaev, Ei, Riabchikova, Av, Zhukov, Ln, Shishkina, Aa, Medvedev, Va, Petrishchenko, An, Sergeev, Aa, Vorob Ev
Publikováno v:
Europe PubMed Central
A setup for the generation and studies of mono-disperse microbiological aerosols is described in the paper. Coefficients of 3 microm aerosol deposition in the respiratory tract of mice and rats were refined by using the above setup. The probability o
Autor:
An, Sergeev, Va, Petrishchenko, Iankov Ov, P., Ln, Shishkina, Aa, Sergeev, Av, Kachko, Nn, Kiselev, Va, Ternovoĭ, Va, Sviatchenko
Publikováno v:
Europe PubMed Central
The results of polymerase chain reaction and of DNA sequencing of the Adel2 mutant variant of adenovirus serotype 5, passaged 10 times and capable of selectively infecting and lysing the p53-deficient human tumor cells, are indicative of a high stabi
Autor:
Zhukov VA, Shishkina LN, Safatov AS, Sergeev AA, P'iankov OV, Petrishchenko VA, Zaĭtsev BN, Toporkov VS, Sergeev AN, Nesvizhskiĭ IuV, Vorob'ev AA
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk [Vestn Ross Akad Med Nauk] 2010 (5), pp. 24-9.
Autor:
Zhukov VA, Shishkina LN, Sergeev AA, Pliasunov IV, P'iankov OV, Petrishchenko VA, Sergeev AN, Zaĭtsev BN, Nesvizhskiĭ IuV, Vorob'ev AA
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk [Vestn Ross Akad Med Nauk] 2009 (11), pp. 46-9.
Autor:
Zhukov VA, Shishkina LN, Sergeev AA, Malkova EM, Riabchikova EI, Petrishchenko VA, Sergeev AN, Ustiuzhanina NV, Nesvizhskiĭ IuV, Vorob'ev AA
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk [Vestn Ross Akad Med Nauk] 2008 (2), pp. 12-6.